According to Choudhury et al. (2020), eugenol restricts cancer stem populations in breast cancer through the down-regulation of β-catenin and the restriction of colony formation and stemness, along with the down-regulation of mRNA expression in several markers (Oct4, Notch1, EpCAM) [274]. The gene discussed is EPCAM; the disease is breast carcinoma.